Kaohsiung, Taiwan

Shuo-Chueh Chen

This inventor holds 1 USPTO granted patent. Top assignee: National Sun Yat-Sen University of Kaohsiung. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuo-Chueh Chen. Retrieved from https://idiyas.com/inventor/shuo-chueh-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shuo-Chueh Chen in Cancer Research

Introduction

Shuo-Chueh Chen is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of cancer research. His work focuses on the development of innovative compounds that can potentially inhibit cancer growth and metastasis.

Latest Patents

Shuo-Chueh Chen holds a patent for the pharmaceutical uses of a sulfur-containing compound. This invention relates to the use of the compound in inhibiting activities of a factor associated with cancer metastasis and growth. Specifically, it addresses the inhibition of lung cancer metastasis and growth, showcasing its potential therapeutic applications.

Career Highlights

Chen is affiliated with the National Sun Yat-Sen University in Kaohsiung, where he conducts research and contributes to academic advancements in his field. His dedication to cancer research has positioned him as a key figure in the scientific community.

Collaborations

Some of his notable coworkers include Chih-Yi Chen and Chun-Hsu Pan, who collaborate with him on various research projects aimed at advancing cancer treatment methodologies.

Conclusion

Shuo-Chueh Chen's innovative work in the pharmaceutical applications of sulfur-containing compounds highlights his commitment to combating cancer. His contributions are paving the way for new therapeutic strategies in the fight against this disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…